Generex' insulin mouth spray approved in Lebanon

The USA's Generex Biotechnology Corp says that Lebanon's Ministry of Public Health has approved Generex Oral-lyn, the company's proprietary  oral insulin spray, for importation, marketing, distribution and  commercial sale in the country for the treatment of adults and children  with type 1 or 2 diabetes.

Benta SAL, the company's licensee in Lebanon and the holder of the  largest market share in the supply of pharmaceuticals to Lebanese  hospitals and health institutions, is poised to commence the marketing  and sale of Oral-lyn early in 2009.

The agent is designed to offer a simple, convenient, fast, flexible and  pain-free alternative to prandial injections of insulin. Benta's sales  force will offer the product throughout Lebanon, covering 1,700  pharmacies, 175 hospitals and 23 wholesalers, in addition to public  health institutions and dispensaries. Benta will also implement a  medical education program to introduce the product to endocrinologists,  diabetologists and physicians in Lebanon.